Filings with the SEC since Jun 16, 2014
729 filings, 0 in the last 30 days
Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)
All 63 events
- Oct 31, 2026SEC letter SEC asked 1 question about Form 10-K for the Fiscal Year Ended March 31, 2016 letters 2016-10-20 to 2016-11-01
- Oct 31, 2026SEC letter SEC asked 4 questions about Form S-1 letters 2016-05-31 to 2017-01-04 · no closing letter yet
- Oct 31, 2026SEC letter SEC asked 4 questions about Form 10-12G letters 2015-04-28 to 2015-05-04 · Results discussion (MD&A), Risk factors · no closing letter yet
- Oct 31, 2026SEC letter SEC asked 7 questions about Form 10 letters 2015-03-05 to 2015-04-15 · Risk factors · no closing letter yet
- Sep 30, 2026Offering Sale of 4.4M new shares 424B5 · We are offering to purchasers (i) 4,369,356 shares of our Class A common stock, par value $0.001 per share, at a purchase price of $3.433 per share and (ii) accompanying common warrants to purchase up to an aggregate of 4,369,356 shares of our Class A common stock (each a “Common Warrant”, and colle
- Sep 30, 20268-K Regulation FD disclosure, Other events 8-K items 7.01, 8.01
- Aug 14, 20268-K Quarterly results 8-K item 2.02
- Aug 14, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
- May 29, 2026Offering At-the-market program: up to $250M of common stock 424B5 · In accordance with the terms of the Sales Agreement, pursuant to this prospectus supplement, we may offer and sell shares of our common stock having an aggregate offering price of up to $250,000,000 from time to time through the Sales Agents, reflecting an increase in the maximum aggregate offering
- May 29, 20268-K Material agreement signed 8-K item 1.01
- May 22, 20268-K Shareholder vote results, Other events 8-K items 5.07, 8.01
- May 15, 20268-K Quarterly results 8-K item 2.02
- May 15, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
- Apr 27, 2026Offering Sale of 3.1M new shares 424B5 · We are offering to purchasers 3,076,922 shares of our Class A common stock, par value $0.001 per share, at a purchase price of $2.60 per share, in a registered direct offering.
- Apr 27, 20268-K Unregistered share sale, Regulation FD disclosure, Other events 8-K items 3.02, 7.01, 8.01
- Apr 24, 20268-K Director or officer change 8-K item 5.02
- Apr 13, 20268-K Director or officer change 8-K item 5.02
- Apr 9, 2026Officer CFO and COO change On March 16, 2026, Solana Company (the “Company”) appointed Agustina “Madelene” Gani Tjandrasuwita to serve as the Company’s Chief Operating Officer and Deputy Chief Financial Officer, effective April 6, 2026 (the “Effective Date”).
- Mar 31, 2026Auditor Auditor changed: Baker Tilly US, LLP → CBIZ CPAs P.C. auditor named in the 10-K
- Mar 31, 20268-K Quarterly results 8-K item 2.02
- Mar 31, 202610-K Annual report (10-K) period ended Dec 31, 2025
- Feb 20, 20268-K Other events 8-K item 8.01
- Nov 18, 20258-K Quarterly results 8-K item 2.02
- Nov 18, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
- Nov 12, 2025Late filing Late filing notice: the 10-Q will be late NT 10-Q (Form 12b-25), period ended Sep 30, 2025
- Nov 5, 20258-K Director or officer change, Regulation FD disclosure, Other events 8-K items 5.02, 7.01, 8.01
- Nov 3, 20258-K Regulation FD disclosure 8-K item 7.01
- Oct 31, 20258-K Shareholder vote results 8-K item 5.07
- Oct 29, 20258-K Regulation FD disclosure 8-K item 7.01
- Oct 21, 20258-K Regulation FD disclosure 8-K item 7.01
- Oct 16, 2025Auditor Auditor change 8-K item 4.01
- Sep 29, 20258-K Bylaws or fiscal year changed, Other events 8-K items 5.03, 8.01
- Sep 25, 20258-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
- Sep 22, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · We may offer and sell the securities identified above from time to time in one or more offerings.
- Sep 22, 20258-K Regulation FD disclosure 8-K item 7.01
- Sep 18, 20258-K Material agreement signed, Unregistered share sale, Director or officer change, Bylaws or fiscal year changed, Regulation FD disclosure 8-K items 1.01, 3.02, 5.02, 5.03, 7.01
- Sep 15, 2025Offering At-the-market program: up to $93M of common stock 424B5 · In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having a maximum aggregate offering price of up to $92,800,000 from time to time through the Sales Agents.
- Sep 15, 20258-K Material agreement signed, Unregistered share sale, Regulation FD disclosure, Other events 8-K items 1.01, 3.02, 7.01, 8.01
- Sep 15, 20258-K Material agreement signed, Other events 8-K items 1.01, 8.01
- Aug 14, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
- Jul 21, 20258-K Other events 8-K item 8.01
- Jul 9, 20258-K Other events 8-K item 8.01
- Jul 7, 20258-K Other events 8-K item 8.01
- Jun 27, 20258-K Shareholder rights changed, Bylaws or fiscal year changed 8-K items 3.03, 5.03
- Jun 23, 20258-K Other events 8-K item 8.01
- Jun 20, 20258-K Director or officer change 8-K item 5.02
- Jun 6, 2025Offering Sale of 2.6M new shares 424B4 · See “Description of Securities we are Offering.” We are offering each share and common warrant at a combined public offering price of $3.27 per share and accompanying common warrant.
- Jun 4, 20258-K Other events 8-K item 8.01
- May 23, 2025Offering Shelf registration: shares and other securities, amount not fixed S-1 · Shelf registered
- May 23, 20258-K Shareholder vote results 8-K item 5.07
- May 1, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
- Apr 30, 20258-K Shareholder rights changed, Bylaws or fiscal year changed, Other events 8-K items 3.03, 5.03, 8.01
- Apr 25, 20258-K Material agreement signed, New debt or obligation, Unregistered share sale 8-K items 1.01, 2.03, 3.02
- Apr 22, 20258-K Shareholder vote results 8-K item 5.07
- Apr 4, 20258-K Listing notice 8-K item 3.01
- Mar 26, 2025Offering At-the-market program: up to $1M of common stock 424B5 · Under the Original Prospectus Supplement, we initially registered up to $1,950,000 of our common stock for offer and sale pursuant to the Sales Agreement.
- Mar 25, 202510-K Annual report (10-K) period ended Dec 31, 2024
- Feb 7, 20258-K Listing notice, Director nominations, Other events 8-K items 3.01, 5.08, 8.01
- Jan 24, 20258-K Material agreement signed, Unregistered share sale, Regulation FD disclosure 8-K items 1.01, 3.02, 7.01
- Jan 15, 20258-K Other events 8-K item 8.01
- Dec 23, 20248-K Other events 8-K item 8.01
- Nov 18, 20248-K Regulation FD disclosure, Other events 8-K items 7.01, 8.01
- Nov 12, 202410-Q Quarterly report (10-Q) period ended Sep 30, 2024
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind
All 729
Annual & quarterly 55Current reports (8-K) 205Insiders 217Proxy & votes 27Big owners (13D/13G) 61Shares & debt offered 49SEC letters 40Other 75
| Filed | Form | What it is | Period | |
|---|---|---|---|---|
| May 18, 2026 | DEFA14A | Extra proxy material | all files | |
| May 1, 2026 | DEFA14A | Extra proxy material | all files | |
| Apr 10, 2026 | DEF 14A | Proxy statement | May 21, 2026 | all files |
| Oct 14, 2025 | DEF 14A | Proxy statement | Oct 30, 2025 | all files |
| Oct 2, 2025 | PRE 14A | Oct 2, 2025 | all files | |
| May 2, 2025 | DEF 14A | Proxy statement | May 23, 2025 | all files |
| Apr 22, 2025 | PRE 14A | May 23, 2025 | all files | |
| Mar 25, 2025 | DEF 14A | Proxy statement | Apr 21, 2025 | all files |
| Mar 14, 2025 | PRE 14A | Apr 21, 2025 | all files | |
| Jun 20, 2024 | DEFA14A | Extra proxy material | all files | |
| May 31, 2024 | DEF 14A | Proxy statement | Jun 27, 2024 | all files |
| Apr 21, 2023 | DEF 14A | Proxy statement | May 24, 2023 | all files |
| Apr 7, 2023 | PRE 14A | May 24, 2023 | all files | |
| Apr 22, 2022 | DEF 14A | Proxy statement | May 23, 2022 | all files |
| Apr 8, 2022 | PRE 14A | May 23, 2022 | all files | |
| Apr 23, 2021 | DEF 14A | Proxy statement | May 25, 2021 | all files |
| Dec 10, 2020 | DEFA14A | Extra proxy material | all files | |
| Nov 30, 2020 | DEF 14A | Proxy statement | Dec 28, 2020 | all files |
| Nov 17, 2020 | PRE 14A | Dec 28, 2020 | all files | |
| May 11, 2020 | DEF 14A | Proxy statement | Jun 10, 2020 | all files |
| Apr 28, 2020 | PRE 14A | Jun 10, 2020 | all files | |
| Apr 26, 2019 | DEF 14A | Proxy statement | Jun 12, 2019 | all files |
| May 29, 2018 | DEF 14A | Proxy statement | Jun 28, 2018 | all files |
| May 16, 2018 | PRE 14A | Jun 28, 2018 | all files | |
| May 1, 2017 | DEF 14A | Proxy statement | Jun 5, 2017 | all files |
| Apr 21, 2017 | PRE 14A | Jun 5, 2017 | all files | |
| Aug 16, 2016 | DEF 14A | Proxy statement | Sep 15, 2016 | all files |
Show the other 2 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.